Earnings History Data for Alpine Immune Sciences, Inc. (ALPN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Alpine Immune Sciences, Inc.

Alpine Immune Sciences Inc. operates as a specialty pharmaceutical company. It engages in the discovery and development of protein-based immunotherapies for the treatment of cancer, inflammatory disorders and other diseases. Alpine Immune Sciences Inc., formerly known as Nivalis Therapeutics, is based in Seattle, Washington.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
14-08-2023 AH ALPN Alpine Immune Sciences 643.00 -0.27 -0.38 0.00 Alpine Immune Sciences reports Q2 results
[8/15/2023 10:31 AM]		 13.49 0.24 
(1.85%)		 13.90 0.65 
(4.91%)		 4.82 - 14.92 289,589 270,000 580
23-03-2023 AH 4:05 PM ET
(Mar 23)		 ALPN Alpine Immune Sciences, Inc. 379.25 -0.41 -0.34 -0.52 Alpine Immune Sciences GAAP EPS of -$0.41 misses by $0.14, revenue of $2.78M misses by $8.18M
[3/23/2023 4:08 PM]		 7.42 -0.70 
(-8.62%)		 8.12 0.0 
(0.00%)		 4.82 - 9.95 120,682 120,000 2,025
14-11-2022 AH 4:05 PM ET
(Nov 14)		 ALPN Alpine Immune Sciences, Inc. 258.76 -0.42 -0.10 -0.55 Alpine Immune Sciences GAAP EPS of -$0.42 misses by $0.32, revenue of $8.37M misses by $10.31M
[11/14/2022 4:23 PM]		 6.25 0.51 
(8.89%)		 5.74 0.0 
(0.00%)		 4.82 - 14.40 83,149 120,000 12,619
11-08-2022 AH 4:05 PM ET
(Aug 11)		 ALPN Alpine Immune Sciences 257.00 -0.60 -0.39 0.00 Alpine Immune Sciences GAAP EPS of -$0.60 misses by $0.21, revenue of $5.29M misses by $4.75M
[8/11/2022 5:34 PM]		 8.80 0.22 
(2.56%)		 8.51 -0.07 
(-0.82%)		 6.00 - 14.40 54,769 70,000 3,150
10-11-2021 AH ALPN Alpine Immune Sciences, Inc. 377.90 -0.55 0.00 -0.28 Alpine Immune Sciences EPS misses by $0.56, misses on revenue
[11/10/2021 4:42 PM]		 12.95 -0.61 
(-4.50%)		 12.50 -1.06 
(-7.82%)		 7.70 - 16.37 77,558 60,000 1,000
10-08-2021 AH 4:05 PM ET
(Aug 10)		 ALPN Alpine Immune Sciences, Inc. 211.89 -0.46 -0.29 -0.53 Alpine Immune Sciences EPS misses by $0.12, misses on revenue
[8/10/2021 4:16 PM]		 9.05 -0.14 
(-1.52%)		 9.19 0.0 
(0.00%)		 6.66 - 16.37 39,763 50,000 166
13-05-2021 AH 4:05 PM ET
(May 13)		 ALPN Alpine Immune Sciences, Inc. 286.77 -0.45 -0.32 -0.30 Alpine Immune Sciences EPS misses by $0.09, misses on revenue
[5/13/2021 5:17 PM]		 11.80 0.32 
(2.79%)		 0.0 0.0 
(0.00%)		 2.96 - 16.37 147,320 90,000 0
18-03-2021 AH 4:05 PM ET
(Mar 18)		 ALPN Alpine Immune Sciences, Inc. 317.30 -0.27 -0.28 -0.33 Alpine Immune Sciences EPS beats by $0.04, beats on revenue
[3/18/2021 4:14 PM]		 12.72 -1.09 
(-7.89%)		 13.50 -0.31 
(-2.24%)		 2.05 - 16.37 192,364 130,000 561
12-11-2020 AH 4:05 PM ET
(Nov 12)		 ALPN Alpine Immune Sciences, Inc. 189.09 -0.28 -0.23 -0.62 Alpine Immune Sciences EPS misses by $0.05, misses on revenue
[11/12/2020 4:09 PM]		 8.04 -0.12 
(-1.53%)		 7.75 -0.41 
(-5.02%)		 2.05 - 15.00 45,537 27,830 392
11-08-2020 AH 4:00 PM ET
(Aug 11)		 ALPN Alpine Immune Sciences, Inc. 251.31 -0.53 -0.23 -0.64 9.35 -0.84 
(-8.29%)		 10.50 0.31 
(3.04%)		 2.05 - 15.00 133,250 89,449 440
14-05-2020 AH 4:00 PM ET
(May 14)		 ALPN Alpine Immune Sciences, Inc. 63.01 -0.30 -0.48 -0.70 Alpine Immune Sciences EPS beats by $0.17, beats on revenue
[5/14/2020 4:30 PM]		 3.32 0.27 
(8.85%)		 0.0 0.0 
(0.00%)		 2.05 - 5.95 29,773 20,054 0